PATH250425C21000
- 0.00
- 0.000.00%
UiPath Newsroom
Morgan Stanley Maintains UiPath(PATH.US) With Hold Rating, Maintains Target Price $12
Morgan Stanley Sticks to Its Hold Rating for UiPath (PATH)
UiPath Is Maintained at Neutral by Mizuho
UiPath Analyst Ratings
Mizuho Securities Maintains UiPath(PATH.US) With Hold Rating, Cuts Target Price to $11
FBN Securities Maintains UiPath(PATH.US) With Buy Rating, Maintains Target Price $13
CCORF Maintains UiPath(PATH.US) With Buy Rating, Maintains Target Price $14
RBC Capital Maintains UiPath(PATH.US) With Hold Rating, Maintains Target Price $13
Needham Maintains UiPath(PATH.US) With Hold Rating
RBC Capital Reiterates Sector Perform on UiPath, Maintains $13 Price Target
UiPath Analyst Ratings
UiPath's (PATH) Stock Plummets as Analysts Downgrade Amid Economic Uncertainty
A Quick Look at Today's Ratings for UiPath(PATH.US), With a Forecast Between $10 to $15
UiPath's Hold Rating: Navigating Growth Challenges Amid Macroeconomic and Competitive Pressures
UiPath Is Maintained at Sector Perform by RBC Capital
UiPath Is Maintained at In-Line by Evercore ISI Group
UiPath Price Target Cut to $12.00/Share From $15.00 by Scotiabank
UiPath Is Maintained at Sell by UBS
UiPath Price Target Cut to $10.00/Share From $14.00 by UBS
UiPath Is Maintained at Equal-Weight by Wells Fargo